1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Purity
  • 1.3.1 Overview: Global XPhos Consumption Value by Purity: 2021 Versus 2025 Versus 2032
  • 1.3.2 Research Grade 97%
  • 1.3.3 High Purity Grade ≥98%
• 1.4 Market Analysis by Catalyst Metal System
  • 1.4.1 Overview: Global XPhos Consumption Value by Catalyst Metal System: 2021 Versus 2025 Versus 2032
  • 1.4.2 Palladium-XPhos Systems
  • 1.4.3 Nickel-XPhos Systems
  • 1.4.4 Copper / Gold / Other Metal Systems
• 1.5 Market Analysis by Substrate Type
  • 1.5.1 Overview: Global XPhos Consumption Value by Substrate Type: 2021 Versus 2025 Versus 2032
  • 1.5.2 Aryl Chlorides
  • 1.5.3 Aryl Bromides and Iodides
  • 1.5.4 Heteroaryl Halides
  • 1.5.5 Aryl Sulfonates / Triflates
• 1.6 Market Analysis by Application
  • 1.6.1 Overview: Global XPhos Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.6.2 In-house Pharmaceutical / API Route Development
  • 1.6.3 Academic and Public Research Use
  • 1.6.4 In-house Industrial Fine Chemical Synthesis
• 1.7 Global XPhos Market Size & Forecast
  • 1.7.1 Global XPhos Consumption Value (2021 & 2025 & 2032)
  • 1.7.2 Global XPhos Sales Quantity (2021-2032)
  • 1.7.3 Global XPhos Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Strem Chemicals
  • 2.1.1 Strem Chemicals Details
  • 2.1.2 Strem Chemicals Major Business
  • 2.1.3 Strem Chemicals XPhos Product and Services
  • 2.1.4 Strem Chemicals XPhos Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Strem Chemicals Recent Developments/Updates
• 2.2 Tokyo Chemical Industry Co., Ltd.
  • 2.2.1 Tokyo Chemical Industry Co., Ltd. Details
  • 2.2.2 Tokyo Chemical Industry Co., Ltd. Major Business
  • 2.2.3 Tokyo Chemical Industry Co., Ltd. XPhos Product and Services
  • 2.2.4 Tokyo Chemical Industry Co., Ltd. XPhos Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 Tokyo Chemical Industry Co., Ltd. Recent Developments/Updates
• 2.3 BLD Pharmatech Ltd.
  • 2.3.1 BLD Pharmatech Ltd. Details
  • 2.3.2 BLD Pharmatech Ltd. Major Business
  • 2.3.3 BLD Pharmatech Ltd. XPhos Product and Services
  • 2.3.4 BLD Pharmatech Ltd. XPhos Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 BLD Pharmatech Ltd. Recent Developments/Updates

3 Competitive Environment: XPhos by Manufacturer

• 3.1 Global XPhos Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global XPhos Revenue by Manufacturer (2021-2026)
• 3.3 Global XPhos Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of XPhos by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 XPhos Manufacturer Market Share in 2025
  • 3.4.3 Top 6 XPhos Manufacturer Market Share in 2025
• 3.5 XPhos Market: Overall Company Footprint Analysis
  • 3.5.1 XPhos Market: Region Footprint
  • 3.5.2 XPhos Market: Company Product Type Footprint
  • 3.5.3 XPhos Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global XPhos Market Size by Region
  • 4.1.1 Global XPhos Sales Quantity by Region (2021-2032)
  • 4.1.2 Global XPhos Consumption Value by Region (2021-2032)
  • 4.1.3 Global XPhos Average Price by Region (2021-2032)
• 4.2 North America XPhos Consumption Value (2021-2032)
• 4.3 Europe XPhos Consumption Value (2021-2032)
• 4.4 Asia-Pacific XPhos Consumption Value (2021-2032)
• 4.5 South America XPhos Consumption Value (2021-2032)
• 4.6 Middle East & Africa XPhos Consumption Value (2021-2032)

5 Market Segment by Purity

• 5.1 Global XPhos Sales Quantity by Purity (2021-2032)
• 5.2 Global XPhos Consumption Value by Purity (2021-2032)
• 5.3 Global XPhos Average Price by Purity (2021-2032)

6 Market Segment by Application

• 6.1 Global XPhos Sales Quantity by Application (2021-2032)
• 6.2 Global XPhos Consumption Value by Application (2021-2032)
• 6.3 Global XPhos Average Price by Application (2021-2032)

7 North America

• 7.1 North America XPhos Sales Quantity by Purity (2021-2032)
• 7.2 North America XPhos Sales Quantity by Application (2021-2032)
• 7.3 North America XPhos Market Size by Country
  • 7.3.1 North America XPhos Sales Quantity by Country (2021-2032)
  • 7.3.2 North America XPhos Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe XPhos Sales Quantity by Purity (2021-2032)
• 8.2 Europe XPhos Sales Quantity by Application (2021-2032)
• 8.3 Europe XPhos Market Size by Country
  • 8.3.1 Europe XPhos Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe XPhos Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific XPhos Sales Quantity by Purity (2021-2032)
• 9.2 Asia-Pacific XPhos Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific XPhos Market Size by Region
  • 9.3.1 Asia-Pacific XPhos Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific XPhos Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America XPhos Sales Quantity by Purity (2021-2032)
• 10.2 South America XPhos Sales Quantity by Application (2021-2032)
• 10.3 South America XPhos Market Size by Country
  • 10.3.1 South America XPhos Sales Quantity by Country (2021-2032)
  • 10.3.2 South America XPhos Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa XPhos Sales Quantity by Purity (2021-2032)
• 11.2 Middle East & Africa XPhos Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa XPhos Market Size by Country
  • 11.3.1 Middle East & Africa XPhos Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa XPhos Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 XPhos Market Drivers
• 12.2 XPhos Market Restraints
• 12.3 XPhos Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of XPhos and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of XPhos
• 13.3 XPhos Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 XPhos Typical Distributors
• 14.3 XPhos Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global XPhos market size was valued at US$ 22.43 million in 2025 and is forecast to a readjusted size of US$ 35.63 million by 2032 with a CAGR of 6.8% during review period.
XPhos, or 2-Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl, is an electron-rich, bulky biaryl monophosphine ligand with the CAS number 564483-18-7. It is widely used to form active transition-metal catalyst systems, especially palladium-based systems for cross-coupling chemistry. Typical applications include Buchwald-Hartwig amination, Suzuki-Miyaura coupling, Negishi coupling, Sonogashira coupling, Heck reaction, Hiyama coupling, Stille coupling and related C–C, C–N and C–O bond-forming reactions.
Based on our research, XPhos is one of the most commercially visible and widely used Buchwald biaryl monophosphine ligands. Its value comes from the combination of an electron-rich dicyclohexylphosphino donor group and a bulky triisopropylbiphenyl backbone, which helps improve reactivity, selectivity and substrate scope in transition-metal-catalyzed cross-coupling reactions. XPhos is especially relevant to Buchwald-Hartwig amination, Suzuki-Miyaura coupling, Negishi coupling, Sonogashira coupling, Heck reaction and pharmaceutical route development.
Public product information indicates that TCI supplies XPhos with a stated purity above 98% and also offers a premeasured encapsulated formulation. Strem has listed pack sizes ranging from research quantities to several hundred grams, while Chem-Impex offers XPhos with a stated purity of at least 99% in multiple pack sizes. BLD Pharmatech and Ambeed also maintain commercial XPhos listings. From a regional perspective, suppliers in the United States, Europe and Japan retain advantages in branded research reagents, standardized quality systems and formulated precatalyst products. Chinese and other Asian suppliers are more active in conventional free-ligand products, custom synthesis and cost-sensitive orders. As the use of palladium-catalyzed coupling processes expands in Asian pharmaceutical, agrochemical and electronic-chemical manufacturing, regional suppliers are increasingly extending their capabilities from gram-scale catalog products to hundred-gram and kilogram-scale custom production.
Demand is anchored by pharmaceutical R&D, CRO/CDMO route development, cross-coupling methodology and fine chemical synthesis. Pharmaceutical and CDMO customers use XPhos for screening and optimizing aryl chloride, heteroaryl halide, amination and coupling routes, while academic users buy smaller quantities for methodology development, substrate scope studies and literature reproduction. The market is not expected to behave like a commodity chemical market. Competition will continue to depend on documentation, purity, lot consistency, availability, technical support and bulk pricing. Substitution risk exists from other substrate-specific Buchwald ligands, but XPhos should retain a stable role as a benchmark ligand in cross-coupling screening and established Pd-catalyzed reaction systems.
Report Scope
This report is a detailed and comprehensive analysis for global XPhos market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Purity and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global XPhos market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global XPhos market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global XPhos market size and forecasts, by Purity and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global XPhos market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for XPhos
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global XPhos market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Strem Chemicals, Tokyo Chemical Industry Co., Ltd., BLD Pharmatech Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
XPhos market is split by Purity and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Purity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Purity
Research Grade 97%
High Purity Grade ≥98%
Market segment by Catalyst Metal System
Palladium-XPhos Systems
Nickel-XPhos Systems
Copper / Gold / Other Metal Systems
Market segment by Substrate Type
Aryl Chlorides
Aryl Bromides and Iodides
Heteroaryl Halides
Aryl Sulfonates / Triflates
Market segment by Application
In-house Pharmaceutical / API Route Development
Academic and Public Research Use
In-house Industrial Fine Chemical Synthesis
Major players covered
Strem Chemicals
Tokyo Chemical Industry Co., Ltd.
BLD Pharmatech Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe XPhos product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of XPhos, with price, sales quantity, revenue, and global market share of XPhos from 2021 to 2026.
Chapter 3, the XPhos competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the XPhos breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Purity and by Application, with sales market share and growth rate by Purity, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and XPhos market forecast, by regions, by Purity, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of XPhos.
Chapter 14 and 15, to describe XPhos sales channel, distributors, customers, research findings and conclusion.